Benefits of transdermal vs daily oral delivery

In the case of oral naltrexone, spikes in plasma concentration of the primary metabolite β-Naltrexol are also seen, increasing the risk of adverse effects. This is not expected with transdermal use.

Transdermal delivery

Patient-friendly, sustained drug delivery

Unmet need

Targeting conditions with a large and growing unmet need

Expedited regulatory pathway

Leveraging established data on the compounds to reduce time needed to be clinic-ready

Patent-protection

Patented formulations specific to different indications